Scottish Biotech ILC Therapeutics Sets Sights on Series A an

ILC's Alfacyte product has potential to become a game-changing antiviral treatment in the ongoing global fight against Covid-19 Scottish biotech ICL Therapeutics has set its sights on a Series A round

Related Keywords

Glasgow , Glasgow City , United Kingdom , Belgium , Scotland , Alan Walker , Robert Kopple , Peter Bains , Head Of Preclinical Development , Department Of Immunology , University Of Strathclyde , Business Wire , Vice President , Global Commercial Operations , Scottish Enterprise , Los Angeles Based , Clinical Trial Authorisation , Preclinical Development , Chief Scientific Officer , Technical Operations , Scottish , Biotech , Herapeutics , Jets , Tights , Series , After , Ecent , Investment , Hound ,